Activity of posaconazole in treatment of experimental disseminated zygomycosis.

Antimicrob Agents Chemother

Department of Medical Microbiology, University Medical Center, St. Radboud, 6500 HB Nijmegen, The Netherlands.

Published: November 2003

Three isolates of zygomycetes were used to produce a disseminated infection in nonimmunocompromised mice. Against all zygomycete strains, amphotericin B significantly prolonged survival. Itraconazole was inactive against Rhizopus microsporus and Rhizopus oryzae but was partially active against Absidia corymbifera. Posaconazole had no beneficial effects against R. oryzae but showed partial activity against A. corymbifera. Posaconazole had a clear dose-response effect against R. microsporus.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC253802PMC
http://dx.doi.org/10.1128/AAC.47.11.3647-3650.2003DOI Listing

Publication Analysis

Top Keywords

corymbifera posaconazole
8
activity posaconazole
4
posaconazole treatment
4
treatment experimental
4
experimental disseminated
4
disseminated zygomycosis
4
zygomycosis three
4
three isolates
4
isolates zygomycetes
4
zygomycetes produce
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!